Neurocholinium 1000 mg/4 ml 4 ml, 5 pcs.

Notropic agent.

Cyticolin, being a precursor of key ultrastructural components of the cell membrane (mainly phospholipids), has a broad spectrum of action: promotes the repair of damaged cell membranes, inhibits the action of phospholipases, preventing the excessive formation of free radicals, and also prevents cell death by acting on apoptosis mechanisms.

In the acute period of stroke it reduces the volume of damaged tissue, improves cholinergic transmission.

In brain injury it reduces the duration of post-traumatic coma and the severity of neurological symptoms.

Cyticolin improves symptoms observed in hypoxia: impaired memory, emotional lability, lack of initiative, difficulty in performing daily activities and self-care.

It is effective in the treatment of cognitive, sensory and motor neurological disorders of degenerative and vascular etiology.

Indications

Active ingredient

Composition

How to take, the dosage

When administered orally – 200-300 mg 3 times a day.

In/v with stroke and brain injury in the acute period – 1-2 g/day depending on the severity of the disease for 3-7 days, with subsequent transition to the intravenous injection or ingestion.

I/m – 0.5-1 g/day.

Interaction

Special Instructions

Contraindications

Side effects

CNS and peripheral nervous system disorders: insomnia, headache, dizziness, agitation, tremor, numbness in paralyzed limbs.

In the digestive system: nausea, decreased appetite, changes in the activity of liver enzymes.

Allergic reactions: rash, skin itching, anaphylactic shock.

Others: fever; in some cases – short-term hypotensive effect, stimulation of the parasympathetic nervous system.

Similarities